The future role of inotropic drugs.
Inotropic drugs have not, as yet, been shown in double-blind, randomised and placebo-controlled trials to be of value in the treatment of heart failure. There are theoretical reasons why inotropic drugs may initiate arrhythmias, worsen ischaemia and possibly even increase mortality.